Fintel reports that on January 30, 2025, JP Morgan downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from Overweight to Underweight. Analyst Price Forecast Suggests 146.36% Upside As of ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 33.55% ...

The list of companies with market caps of $1 trillion or more remains extremely short. However, there's little doubt that ...